Revcovi is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Elapegademase.
Product ID | 10122-502_4404cb41-0794-4af5-848e-163017ab951b |
NDC | 10122-502 |
Product Type | Human Prescription Drug |
Proprietary Name | Revcovi |
Generic Name | Elapegademase-lvlr |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2018-10-05 |
Marketing Category | BLA / |
Application Number | BLA761092 |
Labeler Name | Chiesi USA, Inc. |
Substance Name | ELAPEGADEMASE |
Active Ingredient Strength | 2 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2018-10-05 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
10122-502 | Revcovi | elapegademase-lvlr |
57665-002 | Revcovi | elapegademase-lvlr |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REVCOVI 87300981 5800819 Live/Registered |
LEADIANT BIOSCIENCES LIMITED 2017-01-13 |